West Announces Second Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
West Pharma (WST) Tops Q2 EPS by 3c; Raises Outlook
July 28, 2016 7:34 AM EDTWest Pharma (NYSE: WST) reported Q2 EPS of $0.59, $0.03 better than the analyst estimate of $0.56. Revenue for the quarter came in at $388 million versus the consensus estimate of $384.58 million.
GUIDANCE:
West Pharma sees FY2016 EPS of $2.15-$2.25, versus prior guidance of... More
